arrow_back Back Filing freshness 10-Q FY 2025 SEC EDGAR

download Export Data

HALOZYME THERAPEUTICS, INC.

HALO

$115.11 ▲ +3.67 (+3.29%) at close

18 Visible periods

32 Metrics

Peer-ranked Benchmarks

Price Chart

Health

Good

Neutral

auto_awesome

Analytical Summary

HALOZYME THERAPEUTICS, INC. demonstrates solid fundamentals with strength in Profit Margin (%). However, watch Debt to Equity which shows concerning trends. Consider comparing against peers in the Healthcare sector before making investment decisions.

Market Cap $13.8B

Dividend Yield —

Revenue Growth 37.6% ↗

Op. Margin 33.6% ↘

ROIC 14.5% ↘

FCF / Share $5.38 ↗

Trailing P/E 43.6x

Price / Book 277.8x

FCF Yield 4.7%

Debt / Equity 43.89

info Valuation on last close. End-of-day price, Sep 22, 2026.

18-Year Financial Trajectory

Annual

Metric Value Trend Year over Year Percentile

Revenue Total top-line sales

$1.40B

↑ +37.6% —

Net Income Profit after all expenses

$316.89M

↓ -28.6% —

Operating Margin Operating profit as % of sales

33.6%

↓ -38.2% 89th

FCF / Share Free cash flow per share

$5.38

↑ +45.6% —

Long-Term Debt Long-term obligations

$2.14B

↑ +42.3% —

trending_up

Bullish Indicators

Operating Margin (%)Operating Margin (%) is in the top quartile
Profit Margin (%)Profit Margin (%) is in the top quartile

warning

Bearish Risks

Debt to EquityDebt to Equity is concerning (bottom quartile)

Health Breakdown

Profitability ↓

Financial Health ↑

Cash Quality ↑

Financial view

Statement lens

Choose the reporting cadence, isolate a period range, or search directly for a metric.

Cadence

Annual Quarterly

Range

→

📈 Is growth accelerating? 7 metrics

Metric	FY 2025 Dec 31, 2025 10-K ↗	FY 2024 Dec 31, 2024 10-K ↗	FY 2023 Dec 31, 2023 10-K ↗	FY 2022 Dec 31, 2022 10-K ↗	FY 2021 Dec 31, 2021 10-K ↗	FY 2020 Dec 31, 2020 10-K ↗	FY 2019 Dec 31, 2019 10-K ↗	FY 2018 Dec 31, 2018 10-K ↗	FY 2017 Dec 31, 2017 10-K ↗	FY 2016 Dec 31, 2016 10-K ↗	FY 2015 Dec 31, 2015 10-K ↗	FY 2014 Dec 31, 2014 10-K ↗	FY 2013 Dec 31, 2013 10-K ↗	FY 2012 Dec 31, 2012 10-K ↗	FY 2011 Dec 31, 2011 10-K ↗	FY 2010 Dec 31, 2010 10-K ↗	FY 2009 Dec 31, 2009 10-K ↗	FY 2008 Dec 31, 2008 10-K ↗
Revenue Growth YoY (%)	37.6% Excellent ↑ Excellent Improving Year-over-year change in total revenue Optimal: > 10% vs Sector: Above avg (+369%)	22.4% Excellent ↓ Excellent Declining Year-over-year change in total revenue Optimal: > 10% vs Sector: Above avg (+180%)	25.6% Excellent ↓ Excellent Declining Year-over-year change in total revenue Optimal: > 10% vs Sector: Above avg (+220%)	48.9% Excellent ↑ Excellent Improving Year-over-year change in total revenue Optimal: > 10% vs Sector: Above avg (+511%)	65.7% Excellent ↑ Excellent Improving Year-over-year change in total revenue Optimal: > 10% vs Sector: Above avg (+721%)	36.5% Excellent ↑ Excellent Improving Year-over-year change in total revenue Optimal: > 10% vs Sector: Above avg (+357%)	29.1% Excellent ↑ Excellent Improving Year-over-year change in total revenue Optimal: > 10% vs Sector: Above avg (+263%)	-52.0% Weak ↓ Weak Declining Year-over-year change in total revenue Optimal: > 10% vs Sector: Below avg (-750%)	115.8% Excellent ↑ Excellent Improving Year-over-year change in total revenue Optimal: > 10% vs Sector: Above avg (+1348%)	8.6% Fair ↓ Fair Declining Year-over-year change in total revenue Optimal: > 10% vs Sector: Above avg (+8%)	79.3% Excellent ↑ Excellent Improving Year-over-year change in total revenue Optimal: > 10% vs Sector: Above avg (+891%)	37.5% Excellent ↓ Excellent Declining Year-over-year change in total revenue Optimal: > 10% vs Sector: Above avg (+368%)	29.5% Excellent ↓ Excellent Declining Year-over-year change in total revenue Optimal: > 10% vs Sector: Above avg (+268%)	-24.5% Weak ↓ Weak Declining Year-over-year change in total revenue Optimal: > 10% vs Sector: Below avg (-407%)	311.7% Excellent Excellent Year-over-year change in total revenue Optimal: > 10% vs Sector: Above avg (+3796%)	-0.3% Weak Weak Year-over-year change in total revenue Optimal: > 10% vs Sector: Below avg (-104%)	—	—
EPS Growth YoY (%)	-24.6% Weak ↓ Weak Declining Year-over-year change in earnings per share Optimal: > 10%	64.3% Excellent → Excellent Stable Year-over-year change in earnings per share Optimal: > 10%	43.9% Excellent ↓ Excellent Declining Year-over-year change in earnings per share Optimal: > 10%	-48.3% Weak ↓ Weak Declining Year-over-year change in earnings per share Optimal: > 10%	201.1% Excellent Excellent Year-over-year change in earnings per share Optimal: > 10%	N/M	10.7% Fair Fair Year-over-year change in earnings per share Optimal: > 10%	N/M	—	—	—	—	—	—	—	—	—	—
Net Income Growth YoY (%)	-28.6% Weak ↓ Weak Declining Year-over-year change in net income	57.7% Excellent ↓ Excellent Declining Year-over-year change in net income	39.3% Excellent ↓ Excellent Declining Year-over-year change in net income	-49.8% Weak ↓ Weak Declining Year-over-year change in net income	212.0% Excellent Excellent Year-over-year change in net income	N/M	10.1% Fair Fair Year-over-year change in net income	N/M	N/M	-219.6% Weak ↓ Weak Declining Year-over-year change in net income	52.9% Excellent ↑ Excellent Improving Year-over-year change in net income	18.1% Good ↑ Good Improving Year-over-year change in net income	-55.9% Weak ↓ Weak Declining Year-over-year change in net income	-170.9% Weak ↓ Weak Declining Year-over-year change in net income	62.9% Excellent Excellent Year-over-year change in net income	8.8% Fair Fair Year-over-year change in net income	—	—
FCF Growth YoY (%)	45.6% Excellent ↑ Excellent Improving Year-over-year change in free cash flow	30.5% Excellent ↓ Excellent Declining Year-over-year change in free cash flow	64.6% Excellent ↓ Excellent Declining Year-over-year change in free cash flow	-18.8% Weak Weak Year-over-year change in free cash flow	445.0% Excellent Excellent Year-over-year change in free cash flow	N/M	—	—	—	—	—	—	—	—	—	—	—	—
Revenue CAGR 3Y (%)	28.4% Excellent ↓ Excellent Declining Compound annual revenue growth over 3 years	31.8% Excellent ↓ Excellent Declining Compound annual revenue growth over 3 years	45.8% Excellent ↑ Excellent Improving Compound annual revenue growth over 3 years	49.9% Excellent ↑ Excellent Improving Compound annual revenue growth over 3 years	42.9% Excellent ↑ Excellent Improving Compound annual revenue growth over 3 years	-5.5% Weak ↓ Weak Declining Compound annual revenue growth over 3 years	10.1% Good ↓ Good Declining Compound annual revenue growth over 3 years	4.0% Caution ↓ Caution Declining Compound annual revenue growth over 3 years	61.4% Excellent ↑ Excellent Improving Compound annual revenue growth over 3 years	38.8% Excellent → Excellent Stable Compound annual revenue growth over 3 years	47.2% Excellent ↑ Excellent Improving Compound annual revenue growth over 3 years	10.3% Good ↓ Good Declining Compound annual revenue growth over 3 years	59.0% Excellent Excellent Compound annual revenue growth over 3 years	45.7% Excellent Excellent Compound annual revenue growth over 3 years	—	—	—	—
Revenue CAGR 5Y (%)	39.2% Excellent ↑ Excellent Improving Compound annual revenue growth over 5 years	39.0% Excellent ↑ Excellent Improving Compound annual revenue growth over 5 years	40.4% Excellent ↑ Excellent Improving Compound annual revenue growth over 5 years	15.8% Excellent ↓ Excellent Declining Compound annual revenue growth over 5 years	24.8% Excellent ↑ Excellent Improving Compound annual revenue growth over 5 years	14.7% Excellent ↓ Excellent Declining Compound annual revenue growth over 5 years	21.1% Excellent ↓ Excellent Declining Compound annual revenue growth over 5 years	22.6% Excellent ↓ Excellent Declining Compound annual revenue growth over 5 years	49.5% Excellent ↑ Excellent Improving Compound annual revenue growth over 5 years	21.2% Excellent ↓ Excellent Declining Compound annual revenue growth over 5 years	58.2% Excellent Excellent Compound annual revenue growth over 5 years	40.7% Excellent Excellent Compound annual revenue growth over 5 years	—	—	—	—	—	—
EPS CAGR 3Y (%)	21.3% Excellent ↑ Excellent Improving Compound annual EPS growth over 3 years	7.0% Fair Fair Compound annual EPS growth over 3 years	30.9% Excellent Excellent Compound annual EPS growth over 3 years	—	—	27.3% Excellent Excellent Compound annual EPS growth over 3 years	—	—	—	—	—	—	—	—	—	—	—	—

💰 Are margins durable? 5 metrics

Metric	FY 2025 Dec 31, 2025 10-K ↗	FY 2024 Dec 31, 2024 10-K ↗	FY 2023 Dec 31, 2023 10-K ↗	FY 2022 Dec 31, 2022 10-K ↗	FY 2021 Dec 31, 2021 10-K ↗	FY 2020 Dec 31, 2020 10-K ↗	FY 2019 Dec 31, 2019 10-K ↗	FY 2018 Dec 31, 2018 10-K ↗	FY 2017 Dec 31, 2017 10-K ↗	FY 2016 Dec 31, 2016 10-K ↗	FY 2015 Dec 31, 2015 10-K ↗	FY 2014 Dec 31, 2014 10-K ↗	FY 2013 Dec 31, 2013 10-K ↗	FY 2012 Dec 31, 2012 10-K ↗	FY 2011 Dec 31, 2011 10-K ↗	FY 2010 Dec 31, 2010 10-K ↗	FY 2009 Dec 31, 2009 10-K ↗	FY 2008 Dec 31, 2008 10-K ↗
Operating Margin (%) (%)	33.6% Excellent ↓ Excellent Declining Operating income as a percentage of revenue Optimal: > 15% vs Sector: Above avg (+124%)	54.3% Excellent ↑ Excellent Improving Operating income as a percentage of revenue Optimal: > 15% vs Sector: Above avg (+262%)	40.7% Excellent ↓ Excellent Declining Operating income as a percentage of revenue Optimal: > 15% vs Sector: Above avg (+171%)	40.5% Excellent ↑ Excellent Improving Operating income as a percentage of revenue Optimal: > 15% vs Sector: Above avg (+170%)	62.2% Excellent ↑ Excellent Improving Operating income as a percentage of revenue Optimal: > 15% vs Sector: Above avg (+315%)	53.9% Excellent ↑ Excellent Improving Operating income as a percentage of revenue Optimal: > 15% vs Sector: Above avg (+259%)	-34.5% Weak ↓ Weak Declining Operating income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-330%)	-45.7% Weak ↓ Weak Declining Operating income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-404%)	25.6% Excellent ↑ Excellent Improving Operating income as a percentage of revenue Optimal: > 15% vs Sector: Above avg (+71%)	-56.7% Weak ↑ Weak Improving Operating income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-478%)	-20.3% Weak ↑ Weak Improving Operating income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-236%)	-83.7% Weak ↑ Weak Improving Operating income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-658%)	-146.8% Weak ↑ Weak Improving Operating income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-1079%)	-126.7% Weak ↑ Weak Improving Operating income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-945%)	-35.4% Weak ↑ Weak Improving Operating income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-336%)	-398.2% Weak Weak Operating income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-2755%)	-427.6% Weak Weak Operating income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-2951%)	—
Effective Tax Rate (%) (%)	32.1% Weak ↑ Weak Improving Actual taxes paid relative to pre-tax income Optimal: 15-25%	20.3% Good ↑ Good Improving Actual taxes paid relative to pre-tax income Optimal: 15-25%	19.2% Good ↑ Good Improving Actual taxes paid relative to pre-tax income Optimal: 15-25%	18.8% Good ↑ Good Improving Actual taxes paid relative to pre-tax income Optimal: 15-25%	-62.0% Excellent ↓ Excellent Declining Actual taxes paid relative to pre-tax income Optimal: 15-25%	0.2% Excellent ↑ Excellent Improving Actual taxes paid relative to pre-tax income Optimal: 15-25%	0.0% Excellent ↑ Excellent Improving Actual taxes paid relative to pre-tax income Optimal: 15-25%	-0.7% Excellent ↑ Excellent Improving Actual taxes paid relative to pre-tax income Optimal: 15-25%	-2.2% Excellent ↓ Excellent Declining Actual taxes paid relative to pre-tax income Optimal: 15-25%	-1.1% Excellent Excellent Actual taxes paid relative to pre-tax income Optimal: 15-25%	0.0% Excellent Excellent Actual taxes paid relative to pre-tax income Optimal: 15-25%	—	—	—	—	—	—	—
Profit Margin (%) (%)	22.7% Excellent ↓ Excellent Declining Net income as a percentage of revenue Optimal: > 15% vs Sector: Above avg (+89%)	43.7% Excellent ↓ Excellent Declining Net income as a percentage of revenue Optimal: > 15% vs Sector: Above avg (+264%)	34.0% Excellent ↓ Excellent Declining Net income as a percentage of revenue Optimal: > 15% vs Sector: Above avg (+183%)	30.6% Excellent ↓ Excellent Declining Net income as a percentage of revenue Optimal: > 15% vs Sector: Above avg (+155%)	90.8% Excellent ↑ Excellent Improving Net income as a percentage of revenue Optimal: > 15% vs Sector: Above avg (+657%)	48.2% Excellent ↑ Excellent Improving Net income as a percentage of revenue Optimal: > 15% vs Sector: Above avg (+302%)	-36.9% Weak ↓ Weak Declining Net income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-407%)	-52.9% Weak ↓ Weak Declining Net income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-541%)	19.9% Good ↑ Good Improving Net income as a percentage of revenue Optimal: > 15% vs Sector: Above avg (+66%)	-70.2% Weak ↑ Weak Improving Net income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-685%)	-23.9% Weak ↑ Weak Improving Net income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-299%)	-90.8% Weak ↑ Weak Improving Net income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-856%)	-152.3% Weak ↑ Weak Improving Net income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-1369%)	-126.5% Weak ↑ Weak Improving Net income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-1154%)	-35.2% Weak ↑ Weak Improving Net income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-394%)	-390.8% Weak Weak Net income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-3357%)	-426.9% Weak Weak Net income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-3657%)	—
FCF Margin (%) (%)	46.2% Excellent ↑ Excellent Improving Free cash flow as a percentage of revenue Optimal: > 10%	46.1% Excellent ↓ Excellent Declining Free cash flow as a percentage of revenue Optimal: > 10%	45.0% Excellent ↑ Excellent Improving Free cash flow as a percentage of revenue Optimal: > 10%	35.6% Excellent ↑ Excellent Improving Free cash flow as a percentage of revenue Optimal: > 10%	67.2% Excellent ↑ Excellent Improving Free cash flow as a percentage of revenue Optimal: > 10%	19.8% Good Good Free cash flow as a percentage of revenue Optimal: > 10%	-45.6% Weak Weak Free cash flow as a percentage of revenue Optimal: > 10%	—	—	-36.5% Weak ↑ Weak Improving Free cash flow as a percentage of revenue Optimal: > 10%	-29.2% Weak ↑ Weak Improving Free cash flow as a percentage of revenue Optimal: > 10%	-64.9% Weak ↑ Weak Improving Free cash flow as a percentage of revenue Optimal: > 10%	-94.2% Weak ↑ Weak Improving Free cash flow as a percentage of revenue Optimal: > 10%	-155.3% Weak ↑ Weak Improving Free cash flow as a percentage of revenue Optimal: > 10%	-62.7% Weak ↑ Weak Improving Free cash flow as a percentage of revenue Optimal: > 10%	-337.9% Weak Weak Free cash flow as a percentage of revenue Optimal: > 10%	-304.4% Weak Weak Free cash flow as a percentage of revenue Optimal: > 10%	—
FCF / Net Income (x)	2.03x Excellent ↑ Excellent Improving Free cash flow relative to reported net income Optimal: > 1x	1.05x Fair → Fair Stable Free cash flow relative to reported net income Optimal: > 1x	1.33x Good ↑ Good Improving Free cash flow relative to reported net income Optimal: > 1x	1.16x Fair ↑ Fair Improving Free cash flow relative to reported net income Optimal: > 1x	0.74x Caution ↓ Caution Declining Free cash flow relative to reported net income Optimal: > 1x	0.41x Weak Weak Free cash flow relative to reported net income Optimal: > 1x	1.24x Good Good Free cash flow relative to reported net income Optimal: > 1x	—	—	0.52x Weak ↓ Weak Declining Free cash flow relative to reported net income Optimal: > 1x	1.22x Good ↑ Good Improving Free cash flow relative to reported net income Optimal: > 1x	0.71x Caution ↓ Caution Declining Free cash flow relative to reported net income Optimal: > 1x	0.62x Weak ↓ Weak Declining Free cash flow relative to reported net income Optimal: > 1x	1.23x Good ↑ Good Improving Free cash flow relative to reported net income Optimal: > 1x	1.78x Excellent ↑ Excellent Improving Free cash flow relative to reported net income Optimal: > 1x	0.86x Caution Caution Free cash flow relative to reported net income Optimal: > 1x	0.71x Caution Caution Free cash flow relative to reported net income Optimal: > 1x	—

🎯 Is capital allocation efficient? 3 metrics

Metric	FY 2025 Dec 31, 2025 10-K ↗	FY 2024 Dec 31, 2024 10-K ↗	FY 2023 Dec 31, 2023 10-K ↗	FY 2022 Dec 31, 2022 10-K ↗	FY 2021 Dec 31, 2021 10-K ↗	FY 2020 Dec 31, 2020 10-K ↗	FY 2019 Dec 31, 2019 10-K ↗	FY 2018 Dec 31, 2018 10-K ↗	FY 2017 Dec 31, 2017 10-K ↗	FY 2016 Dec 31, 2016 10-K ↗	FY 2015 Dec 31, 2015 10-K ↗	FY 2014 Dec 31, 2014 10-K ↗	FY 2013 Dec 31, 2013 10-K ↗	FY 2012 Dec 31, 2012 10-K ↗	FY 2011 Dec 31, 2011 10-K ↗	FY 2010 Dec 31, 2010 10-K ↗	FY 2009 Dec 31, 2009 10-K ↗	FY 2008 Dec 31, 2008 10-K ↗
Return on Invested Capital (%)	14.5% Good ↓ Good Declining Return earned on debt + equity capital invested Optimal: > 10%	23.5% Excellent ↓ Excellent Declining Return earned on debt + equity capital invested Optimal: > 10%	17.2% Excellent ↓ Excellent Declining Return earned on debt + equity capital invested Optimal: > 10%	13.0% Good ↓ Good Declining Return earned on debt + equity capital invested Optimal: > 10%	45.4% Excellent ↑ Excellent Improving Return earned on debt + equity capital invested Optimal: > 10%	95.3% Excellent ↑ Excellent Improving Return earned on debt + equity capital invested Optimal: > 10%	-14.2% Weak ↑ Weak Improving Return earned on debt + equity capital invested Optimal: > 10%	-24.6% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	24.8% Excellent ↑ Excellent Improving Return earned on debt + equity capital invested Optimal: > 10%	-50.5% Weak ↑ Weak Improving Return earned on debt + equity capital invested Optimal: > 10%	-38.7% Weak ↑ Weak Improving Return earned on debt + equity capital invested Optimal: > 10%	-54.6% Weak ↑ Weak Improving Return earned on debt + equity capital invested Optimal: > 10%	-213.4% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-54.0% Weak ↑ Weak Improving Return earned on debt + equity capital invested Optimal: > 10%	-143.8% Weak ↑ Weak Improving Return earned on debt + equity capital invested Optimal: > 10%	-210.6% Weak Weak Return earned on debt + equity capital invested Optimal: > 10%	-669.0% Weak Weak Return earned on debt + equity capital invested Optimal: > 10%	—
Return on Capital (%) (%)	18.6% Excellent ↓ Excellent Declining Operating profit relative to total assets Optimal: > 10%	26.7% Excellent ↑ Excellent Improving Operating profit relative to total assets Optimal: > 10%	19.5% Excellent ↓ Excellent Declining Operating profit relative to total assets Optimal: > 10%	14.5% Good ↑ Good Improving Operating profit relative to total assets Optimal: > 10%	25.0% Excellent ↑ Excellent Improving Operating profit relative to total assets Optimal: > 10%	24.9% Excellent ↑ Excellent Improving Operating profit relative to total assets Optimal: > 10%	-11.9% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-15.7% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	15.6% Excellent ↑ Excellent Improving Operating profit relative to total assets Optimal: > 10%	-31.8% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-15.1% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-38.0% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-79.0% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-39.8% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-30.2% Weak Weak Operating profit relative to total assets Optimal: > 10%	-59.4% Weak Weak Operating profit relative to total assets Optimal: > 10%	—	—
Return on Common Equity (%) (%)	—	122.1% Excellent ↓ Excellent Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Above avg (+714%)	—	119.0% Excellent ↑ Excellent Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Above avg (+694%)	204.5% Excellent ↑ Excellent Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Above avg (+1263%)	85.5% Excellent ↑ Excellent Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Above avg (+470%)	-78.7% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-625%)	-32.3% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-315%)	30.2% Excellent ↑ Excellent Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Above avg (+101%)	—	-75.0% Weak ↑ Weak Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-600%)	-165.3% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-1202%)	—	-109.6% Weak ↑ Weak Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-831%)	-181.4% Weak Weak Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-1309%)	-261.6% Weak Weak Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-1844%)	—	—

⚖️ Is the balance sheet risky? 4 metrics

Metric	FY 2025 Dec 31, 2025 10-K ↗	FY 2024 Dec 31, 2024 10-K ↗	FY 2023 Dec 31, 2023 10-K ↗	FY 2022 Dec 31, 2022 10-K ↗	FY 2021 Dec 31, 2021 10-K ↗	FY 2020 Dec 31, 2020 10-K ↗	FY 2019 Dec 31, 2019 10-K ↗	FY 2018 Dec 31, 2018 10-K ↗	FY 2017 Dec 31, 2017 10-K ↗	FY 2016 Dec 31, 2016 10-K ↗	FY 2015 Dec 31, 2015 10-K ↗	FY 2014 Dec 31, 2014 10-K ↗	FY 2013 Dec 31, 2013 10-K ↗	FY 2012 Dec 31, 2012 10-K ↗	FY 2011 Dec 31, 2011 10-K ↗	FY 2010 Dec 31, 2010 10-K ↗	FY 2009 Dec 31, 2009 10-K ↗	FY 2008 Dec 31, 2008 10-K ↗
Debt to Equity (x)	43.89x Weak ↑ Weak Improving Total debt relative to shareholder equity Optimal: < 0.6x vs Sector: Above avg (+7216%)	4.14x Weak ↓ Weak Declining Total debt relative to shareholder equity Optimal: < 0.6x vs Sector: Above avg (+590%)	17.89x Weak ↑ Weak Improving Total debt relative to shareholder equity Optimal: < 0.6x vs Sector: Above avg (+2882%)	8.87x Weak ↑ Weak Improving Total debt relative to shareholder equity Optimal: < 0.6x vs Sector: Above avg (+1378%)	4.00x Weak ↑ Weak Improving Total debt relative to shareholder equity Optimal: < 0.6x vs Sector: Above avg (+566%)	0.00x Excellent ↓ Excellent Declining Total debt relative to shareholder equity Optimal: < 0.6x vs Sector: Below avg (-100%)	4.17x Weak ↑ Weak Improving Total debt relative to shareholder equity Optimal: < 0.6x vs Sector: Above avg (+596%)	0.14x Excellent ↑ Excellent Improving Total debt relative to shareholder equity Optimal: < 0.6x vs Sector: Below avg (-77%)	0.60x Fair ↑ Fair Improving Total debt relative to shareholder equity Optimal: < 0.6x vs Sector: At sector avg	-6.13x Excellent ↓ Excellent Declining Total debt relative to shareholder equity Optimal: < 0.6x vs Sector: Below avg (-1122%)	0.65x Fair ↑ Fair Improving Total debt relative to shareholder equity Optimal: < 0.6x vs Sector: Above avg (+8%)	1.21x Caution ↑ Caution Improving Total debt relative to shareholder equity Optimal: < 0.6x vs Sector: Above avg (+101%)	-2.49x Excellent ↓ Excellent Declining Total debt relative to shareholder equity Optimal: < 0.6x vs Sector: Below avg (-515%)	0.61x Fair Fair Total debt relative to shareholder equity Optimal: < 0.6x vs Sector: At sector avg	0.00x Excellent Excellent Total debt relative to shareholder equity Optimal: < 0.6x vs Sector: Below avg (-100%)	—	—	—
Interest Coverage (x)	41.04x Excellent ↑ Excellent Improving Operating income divided by interest expense Optimal: > 5x	52.20x Excellent ↑ Excellent Improving Operating income divided by interest expense Optimal: > 5x	17.99x Excellent ↓ Excellent Declining Operating income divided by interest expense Optimal: > 5x	15.79x Excellent ↑ Excellent Improving Operating income divided by interest expense Optimal: > 5x	36.66x Excellent ↑ Excellent Improving Operating income divided by interest expense Optimal: > 5x	7.08x Good ↑ Good Improving Operating income divided by interest expense Optimal: > 5x	-5.81x Weak ↓ Weak Declining Operating income divided by interest expense Optimal: > 5x	-3.84x Weak ↓ Weak Declining Operating income divided by interest expense Optimal: > 5x	3.68x Fair ↑ Fair Improving Operating income divided by interest expense Optimal: > 5x	-4.17x Weak ↑ Weak Improving Operating income divided by interest expense Optimal: > 5x	-5.28x Weak ↑ Weak Improving Operating income divided by interest expense Optimal: > 5x	-11.29x Weak ↑ Weak Improving Operating income divided by interest expense Optimal: > 5x	-24.57x Weak Weak Operating income divided by interest expense Optimal: > 5x	-1915.19x Weak Weak Operating income divided by interest expense Optimal: > 5x	—	—	—	—
Net Debt (USD)	$2.01B	$1.39B	$1.38B	$1.27B	$668.54M	$-147.70M	$262.87M	$-23.06M	$-43.60M	$132.46M	$-15.32M	$-11.53M	$22.41M	$-70.24M	$-52.83M	$-83.26M	$-67.46M	$-63.72M
Debt / EBITDA (x)	4.46x Weak ↑ Weak Improving Debt relative to earnings before interest, taxes, depreciation Optimal: < 2x	2.68x Fair ↓ Fair Declining Debt relative to earnings before interest, taxes, depreciation Optimal: < 2x	4.30x Weak ↑ Weak Improving Debt relative to earnings before interest, taxes, depreciation Optimal: < 2x	5.50x Weak ↑ Weak Improving Debt relative to earnings before interest, taxes, depreciation Optimal: < 2x	2.82x Fair ↑ Fair Improving Debt relative to earnings before interest, taxes, depreciation Optimal: < 2x	0.00x Excellent ↑ Excellent Improving Debt relative to earnings before interest, taxes, depreciation Optimal: < 2x	-6.03x Excellent ↓ Excellent Declining Debt relative to earnings before interest, taxes, depreciation Optimal: < 2x	-0.52x Excellent ↑ Excellent Improving Debt relative to earnings before interest, taxes, depreciation Optimal: < 2x	1.50x Good ↑ Good Improving Debt relative to earnings before interest, taxes, depreciation Optimal: < 2x	-2.47x Excellent ↓ Excellent Declining Debt relative to earnings before interest, taxes, depreciation Optimal: < 2x	-1.09x Excellent ↓ Excellent Declining Debt relative to earnings before interest, taxes, depreciation Optimal: < 2x	-0.81x Excellent ↓ Excellent Declining Debt relative to earnings before interest, taxes, depreciation Optimal: < 2x	-0.63x Excellent ↓ Excellent Declining Debt relative to earnings before interest, taxes, depreciation Optimal: < 2x	-0.56x Excellent Excellent Debt relative to earnings before interest, taxes, depreciation Optimal: < 2x	0.00x Excellent Excellent Debt relative to earnings before interest, taxes, depreciation Optimal: < 2x	—	—	—

📊 What does each share earn? 6 metrics

Metric	FY 2025 Dec 31, 2025 10-K ↗	FY 2024 Dec 31, 2024 10-K ↗	FY 2023 Dec 31, 2023 10-K ↗	FY 2022 Dec 31, 2022 10-K ↗	FY 2021 Dec 31, 2021 10-K ↗	FY 2020 Dec 31, 2020 10-K ↗	FY 2019 Dec 31, 2019 10-K ↗	FY 2018 Dec 31, 2018 10-K ↗	FY 2017 Dec 31, 2017 10-K ↗	FY 2016 Dec 31, 2016 10-K ↗	FY 2015 Dec 31, 2015 10-K ↗	FY 2014 Dec 31, 2014 10-K ↗	FY 2013 Dec 31, 2013 10-K ↗	FY 2012 Dec 31, 2012 10-K ↗	FY 2011 Dec 31, 2011 10-K ↗	FY 2010 Dec 31, 2010 10-K ↗	FY 2009 Dec 31, 2009 10-K ↗	FY 2008 Dec 31, 2008 10-K ↗
Revenue per Share (USD)	$11.65	$8.01	$6.29	$4.82	$3.15	$1.96	$1.36	$1.06	$2.32	—	—	—	—	—	—	—	—	—
Basic EPS, GAAP (USD)	$2.64	$3.50	$2.13	$1.48	$2.86	$0.95	$-0.50	$-0.56	$0.46	—	—	—	—	—	—	—	—	—
Free Cash Flow per Share (USD)	$5.38	$3.69	$2.83	$1.72	$2.12	$0.39	$-0.62	—	—	—	—	—	—	—	—	—	—	—
Book Value per Share (USD)	$0.41	$2.95	$0.66	$1.26	$1.43	$1.12	$0.67	$1.74	$1.46	$-0.25	$0.34	$0.33	$-0.17	$0.43	$0.10	$0.20	—	—
Tangible Book Value per Share (USD)	$-12.85	$-3.69	$-6.36	$-5.81	$1.43	$1.12	$0.67	$1.74	$1.46	$-0.25	$0.34	$0.33	$-0.17	$0.43	$0.10	$0.20	—	—
Basic Weighted Avg Shares (shares)	119.84M	126.83M	131.93M	136.84M	140.65M	136.21M	144.33M	143.60M	136.42M	—	—	—	—	—	—	—	—	—

🏦 How resilient is the balance sheet? 3 metrics

Metric	FY 2025 Dec 31, 2025 10-K ↗	FY 2024 Dec 31, 2024 10-K ↗	FY 2023 Dec 31, 2023 10-K ↗	FY 2022 Dec 31, 2022 10-K ↗	FY 2021 Dec 31, 2021 10-K ↗	FY 2020 Dec 31, 2020 10-K ↗	FY 2019 Dec 31, 2019 10-K ↗	FY 2018 Dec 31, 2018 10-K ↗	FY 2017 Dec 31, 2017 10-K ↗	FY 2016 Dec 31, 2016 10-K ↗	FY 2015 Dec 31, 2015 10-K ↗	FY 2014 Dec 31, 2014 10-K ↗	FY 2013 Dec 31, 2013 10-K ↗	FY 2012 Dec 31, 2012 10-K ↗	FY 2011 Dec 31, 2011 10-K ↗	FY 2010 Dec 31, 2010 10-K ↗	FY 2009 Dec 31, 2009 10-K ↗	FY 2008 Dec 31, 2008 10-K ↗
Working Capital (USD)	$648.12M	$946.24M	$633.93M	$608.22M	$809.14M	$133.38M	$457.80M	$278.49M	$379.04M	$201.95M	$109.31M	$136.99M	$69.74M	$112.08M	$46.69M	$74.16M	—	—
LT Debt (USD)	$2.14B	$1.51B	$1.50B	$1.51B	$787.25M	$0.00	$383.05M	$34.87M	$125.14M	$199.23M	$27.97M	$49.86M	$49.77M	$29.66M	$0.00	—	—	—
Total Equity (USD)	$48.81M	$363.82M	$83.81M	$169.80M	$196.95M	$151.05M	$91.77M	$248.89M	$208.37M	$-32.48M	$43.00M	$41.35M	$-19.99M	$48.85M	$10.90M	$20.35M	$6.90M	$15.38M

📋 What is driving earnings? 4 metrics

Metric	FY 2025 Dec 31, 2025 10-K ↗	FY 2024 Dec 31, 2024 10-K ↗	FY 2023 Dec 31, 2023 10-K ↗	FY 2022 Dec 31, 2022 10-K ↗	FY 2021 Dec 31, 2021 10-K ↗	FY 2020 Dec 31, 2020 10-K ↗	FY 2019 Dec 31, 2019 10-K ↗	FY 2018 Dec 31, 2018 10-K ↗	FY 2017 Dec 31, 2017 10-K ↗	FY 2016 Dec 31, 2016 10-K ↗	FY 2015 Dec 31, 2015 10-K ↗	FY 2014 Dec 31, 2014 10-K ↗	FY 2013 Dec 31, 2013 10-K ↗	FY 2012 Dec 31, 2012 10-K ↗	FY 2011 Dec 31, 2011 10-K ↗	FY 2010 Dec 31, 2010 10-K ↗	FY 2009 Dec 31, 2009 10-K ↗	FY 2008 Dec 31, 2008 10-K ↗
Sales/Revenue/Turnover (USD)	$1.40B	$1.02B	$829.25M	$660.12M	$443.31M	$267.59M	$195.99M	$151.86M	$316.61M	$146.69M	$135.06M	$75.33M	$54.80M	$42.33M	$56.09M	$13.62M	$13.67M	—
Depreciation Expense (USD)	$11.39M	$10.26M	$11.08M	$6.49M	$3.00M	$3.28M	$4.07M	$2.39M	$2.16M	$2.41M	$1.68M	$1.76M	$1.23M	$1.08M	$1.10M	$1.51M	$1.44M	—
Net Income, GAAP (USD)	$316.89M	$444.09M	$281.59M	$202.13M	$402.71M	$129.09M	$-72.24M	$-80.33M	$62.97M	$-103.02M	$-32.23M	$-68.38M	$-83.48M	$-53.55M	$-19.77M	$-53.24M	$-58.36M	—
Operating Cash Flow (USD)	$651.56M	$479.06M	$388.57M	$240.11M	$299.44M	$55.45M	$-85.42M	—	—	$-50.38M	$-37.08M	$-47.52M	$-49.34M	$-64.33M	$-34.35M	$-45.39M	$-40.15M	—

⌨️ Keyboard Shortcuts

/ Search

Esc Clear

A Annual

Q Quarterly

1-7 Jump to category

R Reset

bar_chart Data from SEC EDGAR XBRL filings

Synced yesterday 18 years · 68 quarters

HALOZYME THERAPEUTICS, INC.

Analytical Summary

18-Year Financial Trajectory

Bullish Indicators

Bearish Risks

Health Breakdown

Statement lens

Benchmark Lens

Signals

Percentile Rankings

Peer Comparison

Compare HALO with peers